Fixed drug eruption associated with anaesthesia

Fixed drug eruption associated with anaesthesia.

We report the case of a 65-yr-old woman undergoing bronchoscopy for a lobular lesion who received thiopentone to induce anaesthesia that was maintained with sufentanil, vecuronium and isoflurane. She tolerated the procedure well initially, but developed eruptions about her face and fingers within 24 hr of anaesthesia. Treatment with flucinonide cream (0.05%) resolved the eruptions with no lasti...

Balanitis due to fixed drug eruption associated with tetracycline therapy.

An eruption is called 'fixed' if it recurs at the same site after re-exposure to the drug which precipitated the previous lesion. The eruption is commonly erythematous and sharply defined but may be bullous, herpetiform, or urticarial, and can be solitary or widely scattered. The commonest target areas are the trunk and the proximal portions of the limbs and the mouth, eyes, and urethra may som...

A generalized fixed drug eruption associated with mycophenolate

FDE: fixed drug eruption INTRODUCTION Mycophenolate is a reversible inhibitor of inosine monophosphate dehydrogenase, which plays an important role in the production of DNA. This drug is commonly used in several autoimmune and inflammatory conditions, including connective tissue diseases, immunobullous disease, and atopic dermatitis, and in the setting of organ transplantation. Mycophenolate is...

Mucosal fixed drug eruption.

Nimesulide-induced fixed drug eruption.

BACKGROUND Nimesulide is a cyclooxygenase (COX) inhibitor with a high degree of selectivity to COX-2. It is a widely used and well tolerated nonsteroidal antiinflammatory drug that also has analgesic and antipyretic properties. The most frequently reported side effects concern the gastrointestinal tract. Pruritus and skin rash are the most common cutaneous adverse reactions. There are only eigh...